Our LHI Team | Board of Directors
_TIF.png)
Thelma King Thiel
Founder, Chair
Malki De Silva
Co-founder, Operational Executive
Donna Thiel
Board Member
Kathleen Schwarz, MD
Pediatric Gastroenterologist
Board Member
Guanghao Tao
Board Member
David Pound, MD
Gastroenterologist
Board Member
William Schaffner, MD
Professor of Preventive Medicine, Vanderbilt University Medical Center
Board Member
D. Lorne Tyrell, MD, PhD
Founding Director of Li Ka Shing Institute of Virology
Michael Houghton
The Nobel Prize in Physiology or Medicine 2020, Prize motivation: "for the discovery of Hepatitis C virus."
Board Member
Jack Lewin, MD
Chairman of National Coalition on Health Care
Stuart C. Gordon, MD
Gastroenterology, Transplant Hepatology
Board Member
Advocates for Prevention
Our Advisory Board, comprised of talented and open-minded leaders, is committed to helping us address the stigma surrounding liver-related diseases while also promoting primary prevention and liver health education.
President of the Hepatitis B Foundation and Baruch S. Blumberg Institute; Professor and Chair, Department of Translational Research, Adjunct Professor, University of Pennsylvania School of Medicine and Drexel University College of Medicine. Dr. Block is also a Fellow of the US National Academy of Inventors.
Timothy M. Block, PhD
Assistant Vice Dean and Program Leader, Integrated Health Disparities, University of Illinois Extension, College of Agriculture, Consumer and Environmental Sciences and Administrative Director of University of North Chicago Abriendo Caminos Program.
Margarita Teran, MD, PhD
President of the World Hepatitis Alliance, Medical Director of the Center for Asian Health at Saint Barnabas Medical Center and Medical Director of the Chinese Medical Program of Cooperman Barnabas Medical Center.
Zobair M. Younossi, MD, MPH
MPH Adjunct Professor of Law at the Georgetown University Law Center and the Associate Director of the Infectious Diseases Initiative at the O’Neill Institute, overseeing the Hepatitis Policy Project. Sonia focuses on national hepatitis C (HCV) law and policy issues. She is also a part of the O’Neill Institute’s Addiction and Public Policy Initiative.
Sonia Canzater, JD, MPH
Chief Medical Officer at Glympse Bio, member of the Board of Directors of Arbutus Biopharma Corp, former Vice President of Medical Affairs, Gilead and former Medical Director of Liver Transplantation at Cedar-Sinai Medical Center.
Tram Tran, MD, PhD
Professor Emeritus of Internal Medicine at The University of Texas Southwestern Medical Center at Dallas and has excelled in a myriad of roles with prominent universities such as Thomas Jefferson University, and Johns Hopkins University serving as a professor as well as Assistant Dean of Post-Doctoral programs and faculty development.
Willis Maddrey, MD
Former Deputy Surgeon General and Principal Deputy Assistant Secretary for Health, HHS and current Senior Vice President, Chief Strategy Officer, Senior Vice President, Chief Strategy Officer at University of North Texas Health Science Center.
Sylvia Trent-Adams, RN, PhD
Interim chairman and Professor of Medicine, Physiology and Molecular Pathology – Division of Gastroenterology at Virginia Commonwealth University Medical Center and chairman of the NIH NASH Clinical Research Network, the Liver Forum for NASH and Fibrosis and leader of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU.
Arun Sanyal, MD
President of the World Hepatitis Alliance, Medical Director of the Center for Asian Health at Saint Barnabas Medical Center and Medical Director of the Chinese Medical Program of Cooperman Barnabas Medical Center.